“Just follow the procedure and fill in the template!” said the QA/RA officer.

Bruce threw up his hands in frustration.
That’s exactly what they had done! And it was what got the project into a mess in the first place.

By strictly and slavishly following the sample size calculation procedure, the team now faced 379 useless measurements

Measurements that:

📉 Blew up the budget and timeline

🛑 Added no value to patient safety

⚙️ Didn’t improve the device

What was missing? A conversation.


Instead of hiding behind SOPs and templates, Bruce needed a QA/RA partner who would sit with the team, understand the product, and interpret what the regulation really required!

He remembered working with Jenifer in his previous role. She would:

🤝 Be together with R&D in the trenches getting the submission done

📖 Break down the legislation/standards into practical actions

🧪 Find compliant but effective alternatives (e.g. rationales, engineering analysis)

🚀 Help get products to market faster and safer

That kind of partnership between QA/RA and R&D made all the difference.

💡 My takeaway: To succeed in MedTech, QA/RA and R&D must share ownership of the end goal: delivering safe, compliant, and effective products to patients.
SOPs and templates are important, but real collaboration is what brings innovation to market.

👉 I’d love to hear from you:
What’s been your experience?
Where have you seen QA/RA and R&D collaboration succeed (or fail)?

To comment and share your thoughts join the conversation at LinkedIn!

Related posts:

Don’t hesitate to ask us your questions.

Drop an e-mail or contact us via LinkedIn

This website uses cookies to ensure you get the best experience on our website. If you want to get more information about this, please view our privacy policy page.